Tadenan treatment of prostatic adenoma
- Authors: Danilov VV1, Eliseeva EV1, Vasil'chenko AV1, Danilov VV1, Eliseeva EV1, Vasilchenko AV1
-
Affiliations:
- Issue: No 2 (2009)
- Pages: 68-73
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277407
- ID: 277407
Cite item
Full Text
Abstract
About the authors
V V Danilov
E V Eliseeva
A V Vasil'chenko
V V Danilov
E V Eliseeva
A V Vasilchenko
References
- Kirby R., ed. Textbook of benign prostatic hyperplasia. Oxford; 1996. 331-337.
- Breza J., Dzurny O., Borowka A. et al. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. Curr. Med. Res. Opin. 1998; 14 (3): 127-139.
- Desgrandchamps F. Clinical relevance of growth factor antagonists in the treatment of benign prostatic hyperplasia. Eur. Urol. 1997; 32 (suppl. 1): 28-31.
- Levin R. M., Levin S. S., Zhao Y., Buttyan R. Cellular and molecular aspects of bladder hypertrophy. Eur. Urol. 1997; 32 (suppl. 1): 15-21.
- Levin R. M., Das A. K. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol. Res. 2000; 28 (3): 201-209.
- Вишневский Е. Л. и др. Урофлоуметрия. М.: Печатный город; 2004.